8: Disorders of bone and mineral other than osteoporosis

Medical Journal of Australia

Volumn 180, Issue 7, 2004, Pages 354-359

  Prince, Richard L ^a   Glendenning, Paul ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CITRATE CALCIUM; ERGOCALCIFEROL; MAGNESIUM ASPARTATE; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHATE; PREDNISONE; RISEDRONIC ACID; THIAZIDE DIURETIC AGENT; TILUDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

ARTICLE; BONE CANCER; BONE MINERALIZATION; BONE REMODELING; CALCIUM ABSORPTION; CELL ACTIVITY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG ABSORPTION; FRAGILITY FRACTURE; HORMONE ACTION; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; LABORATORY DIAGNOSIS; METABOLIC BONE DISEASE; OSTEOCLAST; OSTEOLYSIS; OSTEOMALACIA; OSTEOPOROSIS; PAGET BONE DISEASE; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PRIMARY HYPERPARATHYROIDISM; RENAL OSTEODYSTROPHY; RICKETS; VITAMIN SUPPLEMENTATION;

EID: 1842779832     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb05977.x     Document Type: Article

References (19)

1. Thacher TD, Fischer PR, Pettifor JM, et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 1999; 341: 563-568.
2. Devine A, Wilson SG, Dick IM, Prince RL. Effects of vitamin D metabolites on intestinal calcium absorption and bone turnover in elderly women. Am J Clin Nutr 2002; 75: 283-288.
3. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783.
4. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351: 805-806.
5. Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985; 313: 70-73.
6. Jan de Beur SM, Levine MA. Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 2002; 87: 2467-2473.
7. Lockitch G, Halstead AC, Albersheim S, et al. Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin Chem 1988; 34: 1622-1625.
8. Friedman NE, Lobaugh B, Drezner MK. Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 1993; 76: 839-844.
9. Major PP, Cook R. Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. Am J Clin Oncol 2002; 25 (6 Suppl 1): S10-S18.
10. Lyles KW, Siris ES, Singer FR, Meunier PJ. A clinical approach to diagnosis and management of Paget's disease of bone. J Bone Miner Res 2001; 16: 1379-1387.
11. Hocking LJ, Lucas GJ, Daroszewska A, et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 2002; 11: 2735-2739.
12. Ooi CG, Walsh CA, Gallagher JA, Fraser WD. Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 2000; 27: 417-421.
13. van Staa TP, Selby P, Leufkens HG, et al. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002; 17: 465-471.
14. Alvarez L, Guanabens N, Peris P, et al. Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease. Bone 2001; 29: 447-452.
15. Glendenning P, Gutteridge DH, Retallack RW, et al. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Aust N Z J Med 1998; 28: 173-178.
16. Walls J, Ratcliffe WA, Howell A, Bundred NJ. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) 1994; 41: 407-413.
17. Grill V, Murray RM, Ho PW, et al. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with pamidronate disodium (APD). J Clin Endocrinol Metab 1992; 74: 1468-1470.
18. Davies M, Fraser WD, Hosking DJ. The management of primary hyperparathyroidism. Clin Endocrinol (Oxf) 2002; 57: 145-155.
19. Bardin T. Musculoskeletal manifestations of chronic renal failure. Curr Opin Rheumatol 2003; 15: 48-54.